Riding on the momentum - MEHECO Brand Re-appeared on PharmChina Shanghai

The 81st PharmChina opened in Shanghai on May 13, 2019. Once again, the subsidiaries of China Meheco took part in the exhibition jointly in the name of “MEHECO” and met with its new and old clients at the National Exhibition and Convention Center in Shanghai. In recent years, the pharmaceutical industry has continued to reform in depth, and the industry keeps witnessing the superposition effect of many medical reform policies. A number of policies, such as Tiered Diagnosis and Treatment, Responsibility System of Critical Illness Insurance Program, Drugs Zero-profit Policy, Reducing the Proportion of Drugs, and Centralized Purchasing of Drugs “4+7”, have had a significant impact on the business structure of the pharmaceutical market. Pharmaceutical enterprises are faced with great opportunities and also severe challenges. How to seize the golden opportunity of industrial development.And how to cope with the challenges in policy change.These have become the major subjects that China Meheco is thinking deeply.